Pre-market: prices are the Thursday September 17 close plus any pre-market quotes. · 94 stories reviewed
Marvell’s data‑center outlook is under scrutiny as its custom silicon push faces growth questions for 2027. The Globe and Mail piece raises the issue, while TechCrunch notes Google DeepMind’s new institute on AGI debate and a UN‑UNICEF test exposing AI model gaps in global data retrieval, underscoring the broader AI ecosystem pressures on data‑center providers. This story ties to GlobalFoundries‑Marvell SiGe capacity expansion (see s11), linking supply‑chain advances to performance gains in AI data centers. Evidence: 0 global articles in 24h (GDELT). Sources: Discovery: custom silicon | TechCrunch – DeepMind institute | TechCrunch – UN data AI test
Desk take: Marvell’s silicon roadmap and SiGe capacity boost are critical levers for AI data‑center growth; monitor supply‑chain execution.
NASA selected SpaceX to launch the StarBurst small‑satellite, aimed at probing neutron‑star mergers and short gamma‑ray bursts. The award highlights SpaceX’s expanding role in scientific missions, complementing its broader space‑data network initiatives. Evidence: 3 of our feeds carry it (GDELT unavailable). Sources: NASA News Release – StarBurst | NASA Media Accreditation | SatNews – Space Data Network
Desk take: SpaceX’s launch contract reinforces its dual‑use capability, tying satellite science to the infrastructure that underpins global connectivity.
ASML’s high‑numerical‑aperture (High‑NA) EUV lithography is cementing its monopoly on leading‑edge chip production, with Intel among the early adopters. The company is also rejecting alternative particle‑accelerator‑based FEL approaches, focusing on its LPP EUV laser‑plasma sources. Evidence: 2 of our feeds carry it (GDELT unavailable). Sources: SemiWiki – High‑NA grip | Tom's Hardware – FEL rejection
Desk take: ASML’s High‑NA dominance will drive next‑gen AI accelerator scaling; watch Intel’s adoption timeline.
GlobalFoundries and Marvell have broadened their multi‑year agreement to boost SiGe production at GF’s Burlington plant, targeting the rising demand for high‑performance optical interconnects in AI infrastructure. Evidence: 2 of our feeds carry it (GDELT unavailable). Sources: DigiTimes – headline | HPCwire – collaboration details
Desk take: Expanded SiGe capacity underpins faster AI data‑center links; aligns with Marvell’s data‑center growth narrative (s3).
The Department of Energy announced the Quantum Genesis Q Competition, offering up to $215 million to domestic firms to achieve milestones toward a fault‑tolerant, scientifically relevant quantum computer. Evidence: 2 of our feeds carry it (GDELT unavailable). Sources: HPCwire – competition launch | Nextgov – funding details
Desk take: Federal funding could accelerate quantum breakthroughs that may eventually reshape AI workloads; keep an eye on awardees.
The U.S. government granted IBM’s Anderon unit a $1 billion contract to produce quantum wafers domestically, signaling a shift from lab‑scale to manufacturing‑scale quantum hardware. Evidence: single‑source in our feeds (GDELT unavailable). Sources: EE Times – award announcement | EE Times – broader India context
Desk take: Federal backing accelerates quantum supply chain; potential downstream impact on secure communications and HPC.
Nvidia CEO Jensen Huang projected a 2× increase in chip shipments for the coming year, reflecting sustained demand for AI accelerators across sectors. Evidence: single‑source in our feeds (GDELT unavailable). Sources: CNBC Technology – Huang’s guidance
Desk take: Nvidia’s aggressive sales outlook underscores booming AI chip demand; dovetails with financing for new data‑center capacity (see s57).
Crusoe secured $3.9 billion in funding to construct AI‑focused data centers, with Nvidia among the investors, highlighting the capital intensity of scaling AI infrastructure. Evidence: single‑source in our feeds (GDELT unavailable). Sources: Data Center Dynamics – funding round
Desk take: Massive financing signals confidence in AI workload growth; aligns with Nvidia’s shipment surge (s46) and broader data‑center supply‑chain dynamics.
host, host (All‑In, 2026‑09‑18): The cost estimate for the California high‑speed rail has risen from $33 billion to $126 billion and now to $236 billion. “The original estimates for California high‑speed rail was $33 billion. It then jumped to $126 billion, and now the newest estimate is $236 billion.” [min 0] NEW. Data unavailable — source URL. Desk take: escalating costs pressure project economics.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics received FDA approval for the only thymic kidney transplant program in the clinic worldwide. Desk take: regulatory clearance could create a unique market position.
host, host (All‑In, 2026‑09‑18): Approximately $15 billion has been spent on the California high‑speed rail project. “about $15 billion spent.” [min 0] NEW. Data unavailable — source URL. Desk take: high sunk costs raise scrutiny of future funding.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics' iViva autologous kidney program aims to start clinical trials in 2028. Desk take: pipeline expansion targets long‑term growth.
Senator Cortese, Senator, California (All‑In, 2026‑09‑18): The state will receive $1 billion per year for the next 20 years for the high‑speed rail project. “a bill that's going to give $1 billion for the next 20 years to the California High Speed Rail Authority.” [min 8] NEW. Data unavailable — source URL. Desk take: steady funding stream mitigates financing risk.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics has built a $28 billion biotech company. Desk take: scale suggests strong capital backing.
unattributed, host (All‑In, 2026‑09‑18): The fraud video posted on X received 140 million views. Desk take: massive reach indicates high viral potential.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics announced the acquisition of Thymune last month. Desk take: acquisition adds gene‑editing expertise.
unattributed, host (All‑In, 2026‑09‑18): The California High Speed Rail Project costs $240 billion to build from Fresno to Modesto. Desk take: cost overruns highlight budgeting challenges.
unattributed, executive (Moonshots, 2026‑09‑15): In the XenoHeart trial, two patients survived over 60 days with xenotransplanted hearts. Desk take: early clinical success boosts therapeutic credibility.
unattributed, superintendent (All‑In, 2026‑09‑17): Sales tax collections for the Richland Parish School Board rose from about 5‑10 % to roughly 60‑70 % after the December 2024 groundbreaking. Desk take: local fiscal health improves, potentially supporting infrastructure spending.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics plans to move to a phase‑3 (or less) XenoHeart trial after 50 patients and expects FDA approval for unlimited heart supply. Desk take: pathway to market could unlock a new therapeutic class.
unattributed, executive (Moonshots, 2026‑09‑15): United Therapeutics announced the acquisition of Thymune last month. Desk take: adds cutting‑edge gene‑editing assets.
| Symbol | Last | Change |
|---|---|---|
| S&P 500 | 7637.76 | ▲ +1.14% |
| Nasdaq | 26418.3 | ▲ +1.69% |
| SOX | 11599.49 | ▲ +3.14% |
| VIX | 15.38 | ▼ -0.39% |
| QQQ | 716.92 | ▲ +1.73% |
| SMH | 560.61 | ▲ +2.76% |
| XLK | 188.06 | ▲ +2.25% |
| XLC | 112.35 | ▼ -0.58% |
| NVDA | 219.34 | ▲ +2.54% |
| AMD | 545.09 | ▲ +6.36% |
| MU | 977.5 | ▲ +5.50% |
| AVGO | 347.3 | ▲ +2.29% |
| TSM | 430.26 | ▲ +3.00% |
| META | 682.31 | ▲ +1.34% |
Snapshot as of 2026-09-18 12:02 UTC.
Supply‑chain constraints and strategic hardware investments are reshaping AI compute and space‑based connectivity.
94 stories were gathered and ranked this morning; the full ranked listing appears in The Full Tape below.
Complete machine-generated listing, ranked by corroboration + relevance + rarity. Nothing filtered: if it was gathered, it is here.